Loading…
CIK 0001844645 • 6 13F filings • May 14, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("pivotal-bioventure-partners-investment-advisor-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC | COM | $33.2M | 10.8%Prev: 18.4% | 1,265,283 SH | Increased-855,225 SH |
| AVALO THERAPEUTICS INC | COM NEW | $8.0M | 2.6% | 434,033 SH | New |
| AVALYN PHARMACEUTICALS INC | COM SHS | $31.8M | 10.3% | 966,792 SH | New |
| BIOAGE LABS INC | COM | $16.0M | 5.2%Prev: 1.7% | 653,374 SH | Increased |
| EVOMMUNE INC | COM SHS | $25.6M | 8.3% | 1,926,943 SH | New |
| IMMUNOME INC | COM | $15.5M | 5.0% | 732,512 SH | New |
| MAPLIGHT THERAPEUTICS INC | COM | $21.9M | 7.1% | 611,446 SH | New |
| OCULIS HOLDING AG | ORDINARY SHARES | $20.9M | 6.8%Prev: 27.7% | 1,506,250 SH | Decreased-794,524 SH |
| RALLYBIO CORP | COM | $4.8M | 1.6%Prev: 0.5% | 300,579 SH | Increased-2,104,065 SH |
| RECURSION PHARMACEUTICALS IN | CL A | $2.2M | 0.7%Prev: 1.9% | 595,518 SH | Decreased |
| TREVI THERAPEUTICS INC | COM | $32.5M | 10.6%Prev: 3.9% | 1,742,672 SH | Increased+596,562 SH |
| VAXCYTE INC | COM | $82.9M | 26.9%Prev: 26.3% | 1,425,470 SH | Increased+120,345 SH |
| ZENAS BIOPHARMA INC | COM | $12.5M | 4.0%Prev: 4.7% | 490,766 SH | Increased-288,279 SH |
| Q2 2026 |
| 13F-HR |
| 0001012975-26-000759 |
| $307.8M |
| View |
| Aug 13, 2025 | Q2 2025 | 13F-HR | 0001012975-25-000438 | $161.3M | View |
| May 14, 2026 | Q1 2026 | 13F-HR | 0001012975-26-000421 | $279.8M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0001012975-25-000233 | $123.6M | View |